W Gerald Newmin insider trades: MultiCell Technologies (MCET) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where W reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 7, 2014 | MCET | ↑ Buy | 1,667,000 | $0.00 | $1K | Direct | Jan 8, 2014 (1d) |
| May 23, 2007 | MCET.OB | ↑ Buy | 50,000 | $0.07 | $4K | Direct | May 25, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About W Gerald Newmin's insider trades
W Gerald Newmin is CEO, Chairman at MultiCell Technologies (MCET). Since May 23, 2007, W has reported 2 open-market purchases worth $5K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), gifts (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MCET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.